Lung Cancer, Nonsmall Cell, Stage I Terminated Phase Trials for Motexafin lutetium (DB05296)

Also known as: NSCLC, Stage I / Stage I NSCLC / Stage I Non-Small Cell Lung Cancer / Non-small Cell Lung Cancer Stage I / Lung cancer non-small cell stage I

IndicationStatusPhase
DBCOND0081601 (Lung Cancer, Nonsmall Cell, Stage I)TerminatedNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00087191EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung CancerDiagnostic